Clinical Trial Update: Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results from evaluating buprenorphine extended-release subcutaneous injection at alternative injection locations for Opioid Use D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-01-07